Home
About
Overview
Sharing Data
ORCID
Help
History (38)
HIV-1 protease inhibitors with a P1 phosphonate modification maintain potency against drug-resistant variants by increased interactions with flap residues.
Smoking outcome expectancies predict smoking during voucher-based treatment for smokers with substance use disorders.
Antigen engineering can play a critical role in the protective immunity elicited by Yersinia pestis DNA vaccines.
Leptospira interrogans serovar icterohaemorrhagiae
Targeting the arginine phosphatase YwlE with a catalytic redox-based inhibitor.
See All 38 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Targeting the arginine phosphatase YwlE with a catalytic redox-based inhibitor.
Fuhrmann J, Subramanian V, Thompson PR. Targeting the arginine phosphatase YwlE with a catalytic redox-based inhibitor. ACS Chem Biol. 2013 Sep 20; 8(9):2024-32.
View in:
PubMed
subject areas
Arginine
Bacillus
Enzyme Inhibitors
Mutagenesis, Site-Directed
Mutation
Organophosphorus Compounds
Oxidation-Reduction
Phosphoprotein Phosphatases
authors with profiles
Paul R Thompson PhD